Proteasome Subunit PSMD1 is a Key Therapeutic Target in Multiple Myeloma | Blood | American Society of Hematology ashpublications.org
Blood (ASH) published a clinical update in Oncology on 03 Feb 2026. The item focuses on Proteasome Subunit PSMD1 is a Key Therapeutic Target in Multiple Myeloma | Blood | American Society of Hematology - ashpublications.org. Open the detail page to review the full original feed content.